Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Advanced Gastric CancerGastro-esophageal Junction Cancer
Interventions
DRUG

AUY922

70mg/m2

DRUG

Docetaxel

Docetaxel 75mg/m2

DRUG

Irinotecan

Iriniotecan 350mg/m2

Trial Locations (36)

704

Novartis Investigative Site, Tainan City

5000

Novartis Investigative Site, Adelaide

6500

Novartis Investigative Site, Bellinzona

10048

Novartis Investigative Site, Taipei

11042

Clinical Research Alliance Dept.ofArenaOncologyAssoc(2), Lake Success

16132

Novartis Investigative Site, Genova

31059

Novartis Investigative Site, Toulouse

33075

Novartis Investigative Site, Bordeaux

33305

Novartis Investigative Site, Kuei-Shan Chiang

41100

Novartis Investigative Site, Modena

47905

Horizon Oncology Center, Lafayette

56100

Novartis Investigative Site, Pisa

69373

Novartis Investigative Site, Lyon

75246

Baylor Health Care System/Sammons Cancer Center Baylor Texas Oncology, Dallas

75702

Tyler Cancer Center Dept.ofTylerCancerCtr. (2), Tyler

80131

Novartis Investigative Site, Napoli

89081

Novartis Investigative Site, Ulm

90033

USC/Kenneth Norris Comprehensive Cancer Center USC/Norris, Los Angeles

90095

University of California at Los Angeles Dept. of UCLA (4), Los Angeles

91054

Novartis Investigative Site, Erlangen

115478

Novartis Investigative Site, Moscow

129128

Novartis Investigative Site, Moscow

169610

Novartis Investigative Site, Singapore

21287-0013

The Sidney Kimmel Cancer Center at Johns Hopkins Hospital Dept. of SKCC @ JHU, Baltimore

H3G 1A4

Novartis Investigative Site, Montreal

00168

Novartis Investigative Site, Roma

3584CX

Novartis Investigative Site, Utrecht

442-723

Novartis Investigative Site, Suwon

443-380

Novartis Investigative Site, Suwon

05505

Novartis Investigative Site, Seoul

Unknown

Novartis Investigative Site, Taipei

06500

Novartis Investigative Site, Ankara

GU2 7XX

Novartis Investigative Site, Surrey

SM2 5PT

Novartis Investigative Site, Sutton

G12 0YN

Novartis Investigative Site, Glasgow

LE7 5WW

Novartis Investigative Site, Leicester

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY